Allogenic grafts or allografts are presently irreplaceable tissue grafts to replace damaged ones or non-functioning organs to restore their normal function. Notable achievements in regenerative medicine have aroused a lot of curiosity among transplant clinicians and researchers.
Iranian Tissue Product Co. (ITP), a Knowledge-based company, launched production line of human acellular allograft, following AATB standards in 2011.Right now its products are marketed inside Iran with a considerable market share. The vision of company is to fulfill the situation that no patient in need of allograft miss his/her life improving treatment due to lack of tissue in the country. Recently, to complete the production/distribution chain new team member. We would be pleased to disclose more details including financial, technical and administrative aspects after reaching any agreement.